2023 Annual Meeting | H96 - I Got Your Back: The Collaborative Relationship of the Department Chair and the Academic Business Administrator (Academic Hub)

Date Sunday 04/23/23

Time 03:00 PM - 03:45 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Academic)

Director(s) Cathy A. Sila, MD, FAAN, Michael R. Vincent, MBA, FACHE

Topic(s) General Neurology

Learning Objectives In this program, a department chair and business administrator will explore how to create and sustain a productive partnership and collaborative relationship. Participants will learn about the complementarity of these department leadership roles, the issues facing neurology departments, and how leaders are working together to solve them, and should come away with ideas for establishing strong working relationships at all levels.

CME Available 0.00 CME credit

Core Competencies Interpersonal and Communication Skills, Professionalism

Program Level Intermediate

Program Tracks Academic, Business of Neurology

Recommended Audience General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Business Administrator

Teaching Styles Case-based, Audience Participation

Event Timeline
03:00 PM - 03:45 PM EST	Speaker	I Got Your Back: The Collaborative Relationship of the Department Chair and the Academic Business Administrator Michael R. Vincent, MBA, FACHE, Cathy A. Sila, MD, FAAN

Faculty Disclosures
Cathy A. Sila, MD, FAAN	The institution of Dr. Sila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syntactx . Dr. Sila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Sila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca .
Michael R. Vincent, MBA, FACHE	Mr. Vincent has nothing to disclose.